A proof-of-concept, open-label trial of weekly exenatide (2 mg, 48 weeks, 50 patients) showed an advantage in the unified multiple system atrophy rating scale (UMSARS, parts I and II combined score) at 48 weeks compared with best medically treated participants, but no difference in more objective secondary measures or biomarkers (neurofilament light chain [NfL], CSF -synuclein oligomers) (165)
The NAFLD-Diabetes Connection The overlap between fatty liver disease and diabetes is significant: Prevalence: An estimated 70% of patients with Type 2 diabetes have some degree of fatty liver disease
they're the same ingredient
Across the studies, GLP-1 drugs showed no evidence of negatively affecting testosterone levels, reproductive hormones, sexual function, or sperm quality
Smriti Choudhary, MD team contact us appointment online Table of Contents: Is Ozempic used for weight loss
literature search and analysis, J.G.X